BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8721774)

  • 1. Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects.
    Sesti G; D'Alfonso R; Vargas Punti MD; Tullio AN; Liu YY; Federici M; Borboni P; Marini MA; Lauro R; Fusco A
    Diabetologia; 1996 Mar; 39(3):289-95. PubMed ID: 8721774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients.
    Trischitta V; Brunetti A; Chiavetta A; Benzi L; Papa V; Vigneri R
    Diabetes; 1989 Dec; 38(12):1579-84. PubMed ID: 2684714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endosomal acidification in normal cells mimics the derangements of cellular insulin and insulin-receptor metabolism observed in non-insulin-dependent diabetes mellitus.
    Benzi L; Cecchetti P; Ciccarone AM; Nardone A; Merola E; Maggiorelli R; Campi F; Di Cianni G; Navalesi R
    Metabolism; 1997 Nov; 46(11):1259-65. PubMed ID: 9361682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.
    Benzi L; Trischitta V; Ciccarone A; Cecchetti P; Brunetti A; Squatrito S; Marchetti P; Vigneri R; Navalesi R
    Diabetes; 1990 Jul; 39(7):844-9. PubMed ID: 2191888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trafficking and processing of insulin and insulin receptors in cultured rat hepatocytes.
    Levy JR; Olefsky JM
    Endocrinology; 1987 Dec; 121(6):2075-86. PubMed ID: 3315635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
    Olefsky JM; Garvey WT; Henry RR; Brillon D; Matthaei S; Freidenberg GR
    Am J Med; 1988 Nov; 85(5A):86-105. PubMed ID: 3057897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes.
    Curto M; Novi RF; Rabbone I; Maurino M; Piccinini M; Mioletti S; Mostert M; Bruno R; Rinaudo MT
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1137-42. PubMed ID: 9426381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation occurs normally in cultured Epstein-Barr virus-transformed lymphocytes from patients with extreme insulin resistance. Discrepancy between downregulation in vivo and in vitro.
    Wagman LD; Lambert SR; McElduff A; Roth J; Gorden P; Taylor SI
    Diabetes; 1984 May; 33(5):421-7. PubMed ID: 6327434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular hyperinsulinism: a metabolic characteristic of obesity with and without Type 2 diabetes: intracellular insulin in obesity and Type 2 diabetes.
    Benzi L; Ciccarone AM; Cecchetti P; DiCianni G; Caricato F; Trincavelli L; Volpe L; Navalesi R
    Diabetes Res Clin Pract; 1999 Dec; 46(3):231-7. PubMed ID: 10624789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
    Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
    Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroendocytosis of insulin in rat adipocytes.
    Levy JR; Olefsky JM
    Endocrinology; 1986 Aug; 119(2):572-9. PubMed ID: 3525121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a type A insulin-resistant patient.
    Grunberger G; Comi RJ; Carpentier JL; Podskalny JM; McElduff A; Taylor SI; Gorden P
    J Lab Clin Med; 1988 Jul; 112(1):122-32. PubMed ID: 3292678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
    Ciaraldi TP; Molina JM; Olefsky JM
    J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.
    Nolan JJ; Ludvik B; Baloga J; Reichart D; Olefsky JM
    Diabetes; 1997 Jun; 46(6):994-1000. PubMed ID: 9166671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-stimulated receptor phosphorylation appears normal in cultured Epstein-Barr virus-transformed lymphocyte cell lines derived from patients with extreme insulin resistance.
    Whittaker J; Zick Y; Roth J; Taylor SI
    J Clin Endocrinol Metab; 1985 Feb; 60(2):381-6. PubMed ID: 2981245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.